Piramal Pharma Solutions (PPS) has been recognised as ‘Industry Partner of the Year’ at the prestigious Global Generics & Biosimilars Awards 2018, held recently in Madrid, Spain. This is the second consecutive year that PPS has won this coveted award. PPS competed with several global peers for this recognition in a category that resonates with the Piramal Group’s core belief of building strong collaborations with its strategic partners.
Vivek Sharma, Chief Executive Officer at Piramal Pharma Solutions said: “We are honoured to receive this award, and I congratulate the Piramal Pharma Solutions team that made this victory possible through its collective efforts and dedication. We at Piramal, focus on customer centricity, quality, and innovation as the foundation for strong collaborations, as we strive to become the ‘Partner of Choice’ for our customers. One of our stated goals is to work with our partners to improve affordability, accelerate timelines and increase accessibility to life-saving medicines that impact human lives. This recognition serves as a testament to the progress that we have made, and I would like to thank our partners for their trust in us, and our peers for their efforts in improving health care. It is gratifying that all of us work in an industry that makes an impact on bettering human life. This recognition motivates us to better ourselves at delivering innovative solutions to our customers and end patients.”
The Global Generics & Biosimilars Awards are amongst the most coveted recognitions in the pharmaceutical industry, that recognise the efforts made by global generics and biosimilars sectors, to make affordable medicines available to more patients across the globe.
